With an eye on mitigating disease spread and encouraging trade, the USDA’s Animal and Plant Health Inspection Service has entered three agreements with…

New Jersey-based biosimulation firm Certara and the FDA like working together so much, they’re expanding their relationship. The pair will team up through 2020…

Hoping to continue its regulatory good fortune, Aratana has completed an FDA submission for its post-surgical pain drug for dogs. If approved, the therapy…

The FDA has received more than 5,000 reports of pets who became ill after eating jerky treats, but the agency still can't explain the source of the…

The FDA is taking steps to rescind its approval of carbadox, an antibiotic used to treat swine, the agency announced April 8. The problem? After re-examining…

The head of the FDA's Foods and Veterinary Medicine program Michael Taylor is leaving the agency in June after more than 5 years in the role. During…

U.K.-based Dechra Pharmaceuticals has spent much of the past year rolling out a global expansion plan that's largely focused on increasing its presence in…

Shares of Aratana Therapeutics jumped 25% to $3.99 a share in after-market trading on January 25, after the company announced it had filed for FDA approval of…

Regulatory